| CtBP1 sustains activity-dependent muscle properties and dampens synaptic, contractile and metabolic changes triggered by denervation | Skeletal muscle |  | | 2026 | 12 | 11 |
|
| Recent advances in the clinical spectrum and pathomechanisms associated with X-linked myopathy with excessive autophagy and other VMA21-related disorders | Journal of neuromuscular diseases | | | 2025 | 19 | 211 |
|
| Intracellular autofluorescence enables the isolation of viable, functional human muscle reserve cells with distinct Pax7 levels and stem cell states | Stem cell research & therapy | | | 2025 | 25 | 9 |
|
| MuSK is a substrate for CaMK2β but this interaction is dispensable for MuSK activation in vivo | Scientific reports | | | 2025 | 24 | 205 |
|
| Harnessing distinct tissue-resident immune niches via S100A9/TLR4 improves ketone, lipid, and glucose metabolism | Endocrinology | | | 2025 | 66 | 464 |
|
| CaMKIIβ deregulation contributes to neuromuscular junction destabilization in Myotonic Dystrophy type I | Skeletal muscle | | | 2024 | 196 | 224 |
|
| Identification of a muscle-specific isoform of VMA21 as a potent actor in X-linked myopathy with excessive autophagy pathogenesis | Human molecular genetics | | | 2023 | 149 | 209 |
|
| Back to basics: Optimization of DNA and RNA transfer in muscle cells using recent transfection reagents | Experimental cell research | | | 2022 | 399 | 529 |
|
| Low expression of ANT1 confers oncogenic properties to rhabdomyosarcoma tumor cells by modulating metabolism and death pathways | Cell Death Discovery | | | 2020 | 366 | 219 |
|
| The TOR pathway at the neuromuscular junction: more than a metabolic player? | Frontiers in Molecular Neuroscience | | | 2020 | 333 | 409 |
|
| mTORC1 and PKB/Akt control the muscle response to denervation by regulating autophagy and HDAC4 | Nature Communications | | | 2019 | 401 | 272 |
|
| mTORC2 affects the maintenance of the muscle stem cell pool | Skeletal Muscle | | | 2019 | 375 | 245 |
|
| mTOR controls embryonic and adult myogenesis via mTORC1 | Development | | | 2019 | 370 | 259 |
|
| Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I | Journal of Clinical Investigation | | | 2017 | 413 | 452 |
|
| “Get the balance right”: pathological significance of autophagy perturbation in neuromuscular disorders | Journal of Neuromuscular Diseases | | | 2016 | 327 | 239 |
|
| Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy |  | | 2016 | 334 | 1 |
|
| Activation of mTORC1 in skeletal muscle regulates whole-body metabolism through FGF21 | Science signaling | | | 2015 | 5 | 0 |
|
| Differential response of skeletal muscles to mTORC1 signaling during atrophy and hypertrophy | Skeletal muscle | | | 2013 | 5 | 5 |
|
| Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice | PloS one | | | 2013 | 5 | 16 |
|
| MTORC1 determines autophagy through ULK1 regulation in skeletal muscle | Autophagy | | | 2013 | 4 | 17 |
|
| Sustained Activation of mTORC1 in Skeletal Muscle Inhibits Constitutive and Starvation-Induced Autophagy and Causes a Severe, Late-Onset Myopathy | Cell metabolism | | | 2013 | 4 | 6 |
|
| Selenoprotein N in skeletal muscle : from diseases to function | Journal of molecular medicine | | | 2012 | 4 | 0 |
|
| Satellite cell loss and impaired muscle regeneration in selenoprotein N deficiency | Human molecular genetics online | | | 2011 | 4 | 0 |
|
| Increased Muscle Stress-Sensitivity Induced by Selenoprotein N Inactivation in Mouse : A Mammalian Model for SEPN1-Related Myopathy | PloS one | | | 2011 | 4 | 4 |
|
| Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans | The journal of clinical investigation | | | 2010 | 5 | 27 |
|
| Selenoprotein N is dynamically expressed during mouse development and detected early in muscle precursors | BMC developmental biology | | | 2009 | 4 | 4 |
|
